Transcriptional regulation of UCP4 by NF-kappaB and its role in mediating protection against MPP+ toxicity

Free Radic Biol Med. 2010 Jul 15;49(2):192-204. doi: 10.1016/j.freeradbiomed.2010.04.002. Epub 2010 Apr 9.

Abstract

Mitochondrial uncoupling protein-4 (UCP4) enhances neuronal cell survival in MPP(+)-induced toxicity by suppressing oxidative stress and preserving intracellular ATP and mitochondrial membrane potential. UCP4 expression is increased by MPP(+), but its regulation is unknown. Using serial human UCP4 promoter-luciferase reporter gene constructs, we identified and characterized several cis-acting elements that can regulate UCP4 expression. Core promoter activity exists within 100 bp upstream of the transcription initiation site (TIS=+1). Both CAAT box (-33/-27) and Sp1 (-62/-49) elements are crucial and act synergistically in its transcription. We identified a NF-kappaB putative binding site at -507/-495. Mutation of this site significantly decreased UCP4 promoter activity. Activation of NF-kappaB by TNFalpha or cycloheximide increased, whereas its inhibition by 4-hydroxy-2-nonenal or transfection of pIkappaBalphaM suppressed, UCP4 promoter activity. NF-kappaB inhibition significantly suppressed the MPP(+)-induced increase in UCP4 expression. MPP(+) increased specific binding of NF-kappaB protein complexes to this site in electrophoretic mobility shift assay. Both UCP4 knockdown and NF-kappaB inhibition exacerbated MPP(+)-induced cell death. We present the first direct evidence that UCP4 is regulated by NF-kappaB, mediated via a functional NF-kappaB site in its promoter region, and that UCP4 has a significant role in NF-kappaB prosurvival signaling, mediating its protection against MPP(+) toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / toxicity*
  • Aldehydes / pharmacology
  • Binding Sites / genetics
  • Cell Death / drug effects
  • Cell Death / genetics
  • Cell Line
  • Humans
  • Membrane Transport Proteins / genetics
  • Membrane Transport Proteins / metabolism*
  • Mitochondrial Uncoupling Proteins
  • Mutagenesis, Site-Directed
  • Mutation / genetics
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • NFI Transcription Factors / genetics
  • NFI Transcription Factors / metabolism
  • Neuroprotective Agents / metabolism*
  • Promoter Regions, Genetic / genetics
  • RNA, Small Interfering / genetics
  • Regulatory Elements, Transcriptional / genetics
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Sp1 Transcription Factor / genetics
  • Sp1 Transcription Factor / metabolism
  • Transcriptional Activation* / drug effects
  • Transcriptional Activation* / genetics

Substances

  • Aldehydes
  • Membrane Transport Proteins
  • Mitochondrial Uncoupling Proteins
  • NF-kappa B
  • NFI Transcription Factors
  • Neuroprotective Agents
  • RNA, Small Interfering
  • SLC25A27 protein, human
  • Sp1 Transcription Factor
  • 4-hydroxy-2-nonenal
  • 1-Methyl-4-phenylpyridinium